Authors:
Plebani, A
Ciravegna, B
Ponte, M
Mingari, MC
Moretta, L
Citation: A. Plebani et al., Interleukin-2 mediated restoration of natural killer cell function in a patient with Griscelli syndrome, EUR J PED, 159(9), 2000, pp. 713-714
Authors:
Mingari, MC
Ponte, M
Vitale, C
Bellomo, R
Moretta, L
Citation: Mc. Mingari et al., Expression of HLA class I-specific inhibitory receptors in human cytolyticT lymphocytes: A regulated mechanism that controls T-cell activation and function, HUMAN IMMUN, 61(1), 2000, pp. 44-50
Authors:
Queirolo, P
Ponte, M
Gipponi, M
Cafiero, F
Peressini, A
Semino, C
Pietra, G
Lionetto, R
Vecchio, S
Ribizzi, I
Melioli, G
Sertoli, MR
Citation: P. Queirolo et al., Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: A phase III pilot trial, ANN SURG O, 6(3), 1999, pp. 272-278
Authors:
Vitale, C
Romagnani, C
Falco, M
Ponte, M
Vitale, M
Moretta, A
Bacigalupo, A
Moretta, L
Mingari, MC
Citation: C. Vitale et al., Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells, P NAS US, 96(26), 1999, pp. 15091-15096
Authors:
Ponte, M
Cantoni, C
Biassoni, R
Tradori-Cappai, A
Bentivoglio, G
Vitale, C
Bertone, S
Moretta, A
Moretta, L
Mingari, MC
Citation: M. Ponte et al., Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor, P NAS US, 96(10), 1999, pp. 5674-5679
Authors:
Bertone, S
Schiavetti, F
Bellomo, R
Vitale, C
Ponte, M
Moretta, L
Mingari, MC
Citation: S. Bertone et al., Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes, EUR J IMMUN, 29(1), 1999, pp. 23-29